Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05428735 · ClinicalTrials.gov registry record · NA
The DRAGON 2 Trial
A NA study of Colorectal Cancer Liver Metastases (CRLM) and Small Future Liver Remnant (FLR), sponsored by Maastricht University.
- Recruiting
- Registry status
- NA
- Development phase
- 348
- Enrollment target
- 20
- Study locations
NCT05428735 is a NA study of Colorectal Cancer Liver Metastases (CRLM) and Small Future Liver Remnant (FLR) that is actively recruiting participants, run by Maastricht University. The registered enrollment target is 348 participants. The trial reports 20 study locations across 14 states.
The verdict
NCT05428735, a NA study of Colorectal Cancer Liver Metastases (CRLM) and Small Future Liver Remnant (FLR), is actively recruiting participants, sponsored by Maastricht University.
- RECRUITING
- Registry status
- NA
- Development phase
- 348 participants
- Enrollment target
- 20
- Study locations
Study Summary
In the randomized controlled DRAGON 2 trial study subjects will be randomized between two arms, PVE alone (control group) and PVE/HVE (interventional group).
Conditions Studied
Interventions
- PROCEDURE Embolization
Study Locations (20)
Other
- McGill University Health Center - Montreal
- IRCCS San Raffaele Hospital - Milan
- Amphia - Breda
- Maxima Medisch Centrum - Eindhoven
- Universitair Medisch Centrum Utrecht - Utrecht
Ontario
- Juravinski Hospital and Cancer Centre - Hamilton
- The Ottawa Hospital - Ottawa
- Sunnybrook Hospital - Toronto
Connecticut
- Yale New Haven Hospital - New Haven
Victoria
- Monash Medical Centre - Clayton
Vienna
- Social Medical Center, South - Vienna
Brussels Capital
- Hôpital Erasme - Brussels
Liège
- CHU de Liège - Liège
Namen
- CHU-UCL Namur site Godinne - Yvoir
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 348 participants |
| Start Date | 2022-04-01 |
| Est. Completion | 2029-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05428735
The ClinicalTrials.gov registry entry for NCT05428735 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 348 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Maastricht University, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Colorectal Cancer Liver Metastases (CRLM) appearing as the primary indexed condition, and to 1 intervention - of which Embolization is the first listed.
NCT05428735 reports 20 study locations spanning 14 distinct geographic areas - top geographies include Other, Ontario, Connecticut.
Frequently Asked Questions
What is clinical trial NCT05428735 about?
NCT05428735 is a clinical study titled "The DRAGON 2 Trial". In the randomized controlled DRAGON 2 trial study subjects will be randomized between two arms, PVE alone (control group) and PVE/HVE (interventional group).
What is the current status of trial NCT05428735?
This trial is currently recruiting. It is a NA study. The enrollment target is 348 participants. The study started on 2022-04-01. Estimated completion is 2029-06-30.
What conditions does trial NCT05428735 study?
This clinical trial studies the following conditions: Colorectal Cancer Liver Metastases (CRLM), Small Future Liver Remnant (FLR).
What interventions are being tested in trial NCT05428735?
The interventions under investigation include: Embolization (PROCEDURE).
Who is sponsoring clinical trial NCT05428735?
This trial is sponsored by Maastricht University, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05428735 being conducted?
This trial has 20 study locations across Connecticut, Victoria, Vienna, Brussels Capital, Liège. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colorectal Cancer Liver Metastases (CRLM)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Colorectal Cancer Liver Metastases (CRLM)
All registered trials for this condition
Small Future Liver Remnant (FLR)
All registered trials for this condition
Connecticut
All trials with a study site in Connecticut
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.